ROOK, Alain H.,GELFAND, Joel M.,WYSOCKA, Maria M.,BENOIT, Bernice M.
申请号：
HK16105153.4
公开号：
HK1217165A
申请日:
2016.05.05
申请国别(地区):
HK
年份:
2016
代理人:
摘要：
The present invention provides methods for treating a subject with cutaneous T cell lymphoma (CTCL). In certain embodiments, a subject is administered an effective amount effective of an IRM compound wherein at least one symptom or clinical sign of CTCL is ameliorated. The present invention further includes a method of increasing a cell-mediated immune response of a cell population that includes cells affected by CTCL. In certain embodiments, an effective amount of the cell population is contacted with an IRM compound wherein at least one cell-mediated immune activity of the cell population is increased.
